[Drug-induced interstitial pneumonia].
Ohta
Ken
K
Department of Medicine, Teikyo University School of Medicine.
Nagase
Hiroyuki
H
Ohbayashi
Ohji
O
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000998:Antiviral Agents / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000150:complications; D004365:Drugs, Chinese Herbal / Q000009:adverse effects; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016898:Interferon-alpha / Q000009:adverse effects; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D011239:Prednisolone / Q000008:administration & dosage; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D004365:Drugs, Chinese Herbal; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D011239:Prednisolone